| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8651759 | The American Journal of the Medical Sciences | 2018 | 9 Pages |
Abstract
Overall, our findings suggest that combining K+ channel blockers with prosurvival Bcl-2 family inhibitors is a promising therapeutic approach in treating leukemia.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Corey J. MS, Cory BS, Aditya MS, Levi J. PhD,